Ankur Drugs & Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 12	Mar ' 11	Mar ' 10	Mar ' 09	Mar ' 08

Sales

153.08

824.00

1,067.53

965.32

673.65

Operating profit

-28.11

123.82

213.21

132.17

105.77

Interest

72.86

108.22

65.97

54.10

24.45

Gross profit

-100.90

16.41

148.87

81.00

81.84

EPS (Rs)

-114.56

-33.67

46.24

19.94

50.96

Other income

0.07

0.81

1.63

2.94

0.52

Stock adjustment

18.68

39.62

-3.72

-46.34

-4.17

Raw material

93.58

571.75

799.38

784.42

535.70

Power and fuel

-

-

-

-

-

Employee expenses

28.91

29.73

20.24

18.44

10.79

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

55.69

25.56

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

40.01

48.63

38.42

-

-

Provisions made

-

10.45

-

20.94

-

Depreciation

66.03

60.81

26.78

20.67

5.22

Taxation

31.27

20.94

34.00

21.80

11.90

Net profit / loss

-221.57

-65.13

89.44

37.13

64.73

Extra ordinary item

-23.37

0.21

1.34

-1.42

-

Prior year adjustments

-

-

-

0.01

-

Equity capital

19.34

19.34

19.34

18.62

12.70

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

161.21

146.02

122.21

119.00

91.70

Agg.of non promotoholding (%)

83.35

75.49

63.19

63.92

72.20

OPM (%)

-18.36

15.03

19.97

13.69

15.70

GPM (%)

-65.89

1.99

13.92

8.37

12.14

NPM (%)

-144.68

-7.90

8.36

3.83

9.60